阿特苏纳酸通过CCR3/NF-κB通路缓解慢性过敏性鼻炎和喘综合征:综合分析
Zhi-Qiang Zhang1, You-Wei Bao1, Hongyou Wang2
1Department of Otorhinolaryngology, Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
International immunopharmacology
|September 19, 2025
概括
阿特苏纳酸 (ART) 通过减少炎症和免疫反应,有效治疗慢性过敏性鼻炎和喘综合征 (CARAS). 这项研究突出了ART ART的重点.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性过敏性鼻炎和喘综合征 (CARAS) 是一种复杂的炎症状况,影响上下呼吸道.
- 目前对CARAS的治疗选择有限.
- 阿尔特苏纳酸 (ART) 是一种阿尔特米西宁衍生物,具有抗炎性质,但其在CARAS中的有效性尚未得到充分证实.
研究的目的:
- 在CARAS的小鼠模型中研究Artesunate (ART) 的治疗机制.
- 阐明CCR3/NF-κB信号通路在ART治疗效果中的作用.
- 确定关键的分子点和途径,由ART调制.
主要方法:
- 建立了一个CARAS小鼠模型,用于在体内评估ART.
- 采用网络药理学,RNA测序和机器学习来识别目标和途径.
- 利用分子对接,分子动力学模拟和西方模糊来评估ART-目标相互作用和信号通路调制.
主要成果:
- 在CARAS小鼠中,ART治疗显著降低了炎症,组织损伤,并恢复了上皮质完整性.
- 在ART下降了血清IgE和Th2细胞因子 (IL-4,IL-5,IL-13).
- 网络药理学和机器学习将STAT3确定为关键目标,ART显示出高结合亲和力并抑制CCR3/NF-κB通路.
结论:
- 阿特苏纳酸 (ART) 在改善CARAS方面显示出显著的治疗潜力.
- 通过抑制炎症和通过CCR3/NF-κB轴调节免疫信号来发挥其作用.
- 这些发现支持ART作为CARAS治疗的有希望的候选人.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K


